Health Insurance Review & Assessment Service, Wonju, Korea.
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
Int J Infect Dis. 2022 Sep;122:345-351. doi: 10.1016/j.ijid.2022.06.013. Epub 2022 Jun 12.
The Korean government published the first National Action Plan (NAP) on antimicrobial resistance (AMR) in August 2016, followed by a second plan in November 2021. The objective of this study was to analyze changes in antibiotic use patterns after the implementation of the NAP in South Korea.
We analyzed National Health Insurance claims data for hospitals and clinics from January 2011 to December 2020. Consumption was measured using a defined daily dose per 1000 inhabitants per day (DID). We analyzed data for each year, dimension, and category of the Access, Watch, Reserve classification system by the World Health Organization. Monthly inpatient and outpatient antibiotic use were calculated, and an interrupted time-series (ITS) analysis to assess the trend in antibiotic use was conducted.
The consumption of antibiotics increased from 25.78 DID in 2011 to 29.06 DID in 2016, then decreased in 2017 after the implementation of the NAP on AMR. The watch group showed a temporal decrease after the implementation of the NAP; however, these figures increased until 2019, and the reserve group showed a downward trend beginning in 2017. According to the ITS analysis, the level (β) and the slope of the trend (β) of total antibiotic use decreased by 0.17 and 0.001, respectively. After implementation of the NAP, antibiotic use was reduced from 7.18 DID in 2016 to 4.84 DID in 2017 for amoxicillin and beta-lactamase inhibitors, 0.86 DID to 0.70 DID for ciprofloxacin, and 0.66 DID to0.66 DID for levofloxacin.
After the implementation of the NAP in South Korea, antibiotic use in terms of total antibiotics and fluoroquinolone in the watch and reserve groups decreased. Further policies to improve the use of antibiotics in the watch and reserve groups are needed.
2016 年 8 月,韩国政府发布了首个抗菌素耐药性(AMR)国家行动计划(NAP),随后于 2021 年 11 月发布了第二个 NAP。本研究的目的是分析韩国实施 NAP 后抗生素使用模式的变化。
我们分析了 2011 年 1 月至 2020 年 12 月医院和诊所的国家健康保险索赔数据。使用每 1000 名居民每天的定义日剂量(DID)来衡量消耗量。我们按世界卫生组织的准入、监测、储备分类系统的每个年度、维度和类别进行分析。计算了每月住院和门诊抗生素的使用量,并进行了中断时间序列(ITS)分析,以评估抗生素使用的趋势。
抗生素的消耗量从 2011 年的 25.78 DID 增加到 2016 年的 29.06 DID,然后在 2017 年实施 AMR NAP 后减少。监测组在实施 NAP 后呈现出时间上的下降趋势;然而,这些数字直到 2019 年才增加,储备组从 2017 年开始呈下降趋势。根据 ITS 分析,总抗生素使用的水平(β)和趋势斜率(β)分别降低了 0.17 和 0.001。实施 NAP 后,阿莫西林和β-内酰胺酶抑制剂的抗生素使用量从 2016 年的 7.18 DID 减少到 2017 年的 4.84 DID,环丙沙星的抗生素使用量从 0.86 DID 减少到 0.70 DID,左氧氟沙星的抗生素使用量从 0.66 DID 减少到 0.66 DID。
韩国实施 NAP 后,监测和储备组中抗生素的总使用量和氟喹诺酮类抗生素的使用量减少。需要进一步制定政策,以改善监测和储备组中抗生素的使用。